✦ LIBER ✦

Optimizing Anthracycline Therapy for Node Positive Breast Cancer

✍ Scribed by Dr Fatima Cardoso, Gul Atalay, Martine J. Piccart

Book ID: 120840421
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2002
Tongue: English
Weight: 149 KB
Volume: 1
Category: Article
ISSN: 0099-7374
DOI: 10.2165/00024669-200201040-00003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Which anthracycline dose optimal in node

Which anthracycline dose optimal in node-positive breast cancer?

📂 Article 📅 2001 🏛 Adis International Limited (now part of Wolters Kl ⚖ 152 KB

Adjuvant Therapy for Patients Who Have N

Adjuvant Therapy for Patients Who Have Node-Positive Breast Cancer

✍ Chu, Quyen D.; McDonald, John C.; Li, Benjamin D.L. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 187 KB

Docetaxel in combination therapy for nod

Docetaxel in combination therapy for node-positive, early-stage breast cancer

✍ Miguel Martín 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 548 KB

Docetaxel in sequential therapy for node

Docetaxel in sequential therapy for node-positive, early-stage breast cancer

✍ Henri Roché 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 307 KB

Anthracycline-free therapy for HER2-ampl

Anthracycline-free therapy for HER2-amplified breast cancer

✍ Gennari, Alessandra; Mastro, Lucia Del 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 212 KB

Adjuvant Docetaxel for Node-Positive Bre

Adjuvant Docetaxel for Node-Positive Breast Cancer

✍ Martin, Miguel; Pienkowski, Tadeusz; Mackey, John; Pawlicki, Marek; Guastalla, J 📂 Article 📅 2005 🏛 Massachusetts Medical Society 🌐 English ⚖ 138 KB